Please enable JavaScript to continue using this application.

Compare $ANVS vs $IBIO | Chartloom

Compare

$ANVS vs $IBIO

Annovis Bio Inc · iBio Inc

ANVS

Annovis Bio Inc

IBIO

iBio Inc

Compare $ANVS vs $IBIO

Comparing Annovis Bio Inc and iBio Inc

ANVSAnnovis Bio Inc

IBIOiBio Inc

ANVSAnnovis Bio Inc

Market cap

$42M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-66.8%

52W performance

-46.7%

FCF yield

-103.4%

IBIOiBio Inc

Market cap

$43M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-75.0%

YTD performance

-56.9%

52W performance

0.5%

FCF yield

-55.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANVS

IBIO

Detailed metrics comparison

ANVS

Annovis Bio Inc

IBIO

iBio Inc

Market Cap

ANVS$42M

IBIO$43M

Enterprise Value

ANVS$23M

IBIO$-13M

Price

ANVS$1.21

IBIO$0.87

P/E Ratio

ANVSN/A

IBION/A

P/S Ratio

ANVS0.00x

IBIO432.71x

EV/Sales

ANVS0.00x

IBIO-131.24x

EV/EBITDA

ANVS0.00x

IBIO0.00x

P/B Ratio

ANVS16.11x

IBIO0.80x

P/FCF Ratio

ANVSN/A

IBION/A

EV/FCF

ANVS-0.54x

IBIO0.55x

PEG Ratio

ANVSN/A

IBION/A

Forward P/E (NTM)

ANVSN/A

IBION/A

Forward P/S (NTM)

ANVSN/A

IBION/A

Revenue (TTM)

ANVS$0

IBIO$100K

Revenue Growth (YoY)

ANVSN/A

IBIO-75.0%

Forward Rev Growth

ANVS507.4%

IBIO33.3%

Gross Margin (TTM)

ANVS0.0%

IBIO52.1%

Operating Margin (TTM)

ANVS0.0%

IBIO0.0%

EBITDA Margin (TTM)

ANVS0.0%

IBIO-24492.0%

Net Margin (TTM)

ANVS0.0%

IBIO-33044.0%

FCF Margin (TTM)

ANVSN/A

IBIO-23796.0%

Net Income (TTM)

ANVS$-50M

IBIO$-33M

FCF (TTM)

ANVS$-43M

IBIO$-24M

EPS (TTM)

ANVS-$1.32

IBIO-$0.23

ROE (TTM)

ANVS-31808.0%

IBIO-4792.0%

ROA (TTM)

ANVS-25878.0%

IBIO-4216.0%

ROIC (TTM)

ANVS-31808.0%

IBIO-4779.0%

Cash

ANVS$19M

IBIO$56M

Debt

ANVS$0

IBIO$0

Net Cash/Debt

ANVS$19M

IBIO$56M

Current Ratio (TTM)

ANVS3.47x

IBIO7.85x

Quick Ratio (TTM)

ANVS2.95x

IBIO7.59x

Debt/Equity (TTM)

ANVS0.00x

IBIO0.91x

Debt/Assets (TTM)

ANVS0.0%

IBIO0.0%

Interest Coverage (TTM)

ANVSN/A

IBION/A

Net Debt/EBITDA (TTM)

ANVS0.00x

IBIO0.00x

Beta

ANVS1.32

IBIO1.42

52W Performance

ANVS-46.7%

IBIO0.5%

YTD Performance

ANVS-66.8%

IBIO-56.9%

% from 52W High

ANVS-78.0%

IBIO-77.2%

% from 52W Low

ANVS16.3%

IBIO11.5%

Asset Turnover (TTM)

ANVS0.00x

IBIO0.01x

FCF Yield (TTM)

ANVS-103.4%

IBIO-55.0%

Earnings Yield (TTM)

ANVS-118.1%

IBIO-76.4%

Dividend Yield (TTM)

ANVSN/A

IBION/A

Rule of 40

ANVS0.0

IBIO-23,871.0

EV/GP/RG

ANVSN/A

IBION/A

Ticker research

View ANVS research View IBIO research

Metric	ANVS Annovis Bio Inc	IBIO iBio Inc
Market & Valuation
Market Cap	$42M	$43M
Enterprise Value	$23M	$-13M
Price	$1.21	$0.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	432.71x
EV/Sales	0.00x	-131.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.11x	0.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.54x	0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$100K
Revenue Growth (YoY)	N/A	-75.0%
Forward Rev Growth	507.4%	33.3%
Profitability
Gross Margin (TTM)	0.0%	52.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-24492.0%
Net Margin (TTM)	0.0%	-33044.0%
FCF Margin (TTM)	N/A	-23796.0%
Net Income (TTM)	$-50M	$-33M
FCF (TTM)	$-43M	$-24M
EPS (TTM)	-$1.32	-$0.23
ROE (TTM)	-31808.0%	-4792.0%
ROA (TTM)	-25878.0%	-4216.0%
ROIC (TTM)	-31808.0%	-4779.0%
Financial Health
Cash	$19M	$56M
Debt	$0	$0
Net Cash/Debt	$19M	$56M
Current Ratio (TTM)	3.47x	7.85x
Quick Ratio (TTM)	2.95x	7.59x
Debt/Equity (TTM)	0.00x	0.91x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	1.42
52W Performance	-46.7%	0.5%
YTD Performance	-66.8%	-56.9%
% from 52W High	-78.0%	-77.2%
% from 52W Low	16.3%	11.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-103.4%	-55.0%
Earnings Yield (TTM)	-118.1%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-23,871.0
EV/GP/RG	N/A	N/A
Ticker research	View ANVS research	View IBIO research

Valuation

P/S Ratio

ANVS

0.00x

IBIO

432.71x

EV/FCF

ANVS

-0.54x

IBIO

0.55x

Growth & revenue

Revenue Growth TTM

IBIO

-75.0%

Forward Revenue Growth

ANVS

507.4%

IBIO

33.3%

Profitability & performance

Gross Margin

IBIO

52.1%

ANVS

0.0%

ROE

IBIO

-4792.0%

ANVS

-31808.0%

FCF Yield %

IBIO

-55.0%

ANVS

-103.4%

52-Week Performance

IBIO

0.5%

ANVS

-46.7%

Detailed metrics comparison

ANVS

Annovis Bio Inc

IBIO

iBio Inc

Market Cap

ANVS$42M

IBIO$43M

Enterprise Value

ANVS$23M

IBIO$-13M

Price

ANVS$1.21

IBIO$0.87

P/E Ratio

ANVSN/A

IBION/A

P/S Ratio

ANVS0.00x

IBIO432.71x

EV/Sales

ANVS0.00x

IBIO-131.24x

EV/EBITDA

ANVS0.00x

IBIO0.00x

P/B Ratio

ANVS16.11x

IBIO0.80x

P/FCF Ratio

ANVSN/A

IBION/A

EV/FCF

ANVS-0.54x

IBIO0.55x

PEG Ratio

ANVSN/A

IBION/A

Forward P/E (NTM)

ANVSN/A

IBION/A

Forward P/S (NTM)

ANVSN/A

IBION/A

Revenue (TTM)

ANVS$0

IBIO$100K

Revenue Growth (YoY)

ANVSN/A

IBIO-75.0%

Forward Rev Growth

ANVS507.4%

IBIO33.3%

Gross Margin (TTM)

ANVS0.0%

IBIO52.1%

Operating Margin (TTM)

ANVS0.0%

IBIO0.0%

EBITDA Margin (TTM)

ANVS0.0%

IBIO-24492.0%

Net Margin (TTM)

ANVS0.0%

IBIO-33044.0%

FCF Margin (TTM)

ANVSN/A

IBIO-23796.0%

Net Income (TTM)

ANVS$-50M

IBIO$-33M

FCF (TTM)

ANVS$-43M

IBIO$-24M

EPS (TTM)

ANVS-$1.32

IBIO-$0.23

ROE (TTM)

ANVS-31808.0%

IBIO-4792.0%

ROA (TTM)

ANVS-25878.0%

IBIO-4216.0%

ROIC (TTM)

ANVS-31808.0%

IBIO-4779.0%

Cash

ANVS$19M

IBIO$56M

Debt

ANVS$0

IBIO$0

Net Cash/Debt

ANVS$19M

IBIO$56M

Current Ratio (TTM)

ANVS3.47x

IBIO7.85x

Quick Ratio (TTM)

ANVS2.95x

IBIO7.59x

Debt/Equity (TTM)

ANVS0.00x

IBIO0.91x

Debt/Assets (TTM)

ANVS0.0%

IBIO0.0%

Interest Coverage (TTM)

ANVSN/A

IBION/A

Net Debt/EBITDA (TTM)

ANVS0.00x

IBIO0.00x

Beta

ANVS1.32

IBIO1.42

52W Performance

ANVS-46.7%

IBIO0.5%

YTD Performance

ANVS-66.8%

IBIO-56.9%

% from 52W High

ANVS-78.0%

IBIO-77.2%

% from 52W Low

ANVS16.3%

IBIO11.5%

Asset Turnover (TTM)

ANVS0.00x

IBIO0.01x

FCF Yield (TTM)

ANVS-103.4%

IBIO-55.0%

Earnings Yield (TTM)

ANVS-118.1%

IBIO-76.4%

Dividend Yield (TTM)

ANVSN/A

IBION/A

Rule of 40

ANVS0.0

IBIO-23,871.0

EV/GP/RG

ANVSN/A

IBION/A

Ticker research

View ANVS research View IBIO research

Metric	ANVS Annovis Bio Inc	IBIO iBio Inc
Market & Valuation
Market Cap	$42M	$43M
Enterprise Value	$23M	$-13M
Price	$1.21	$0.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	432.71x
EV/Sales	0.00x	-131.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.11x	0.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.54x	0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$100K
Revenue Growth (YoY)	N/A	-75.0%
Forward Rev Growth	507.4%	33.3%
Profitability
Gross Margin (TTM)	0.0%	52.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-24492.0%
Net Margin (TTM)	0.0%	-33044.0%
FCF Margin (TTM)	N/A	-23796.0%
Net Income (TTM)	$-50M	$-33M
FCF (TTM)	$-43M	$-24M
EPS (TTM)	-$1.32	-$0.23
ROE (TTM)	-31808.0%	-4792.0%
ROA (TTM)	-25878.0%	-4216.0%
ROIC (TTM)	-31808.0%	-4779.0%
Financial Health
Cash	$19M	$56M
Debt	$0	$0
Net Cash/Debt	$19M	$56M
Current Ratio (TTM)	3.47x	7.85x
Quick Ratio (TTM)	2.95x	7.59x
Debt/Equity (TTM)	0.00x	0.91x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	1.42
52W Performance	-46.7%	0.5%
YTD Performance	-66.8%	-56.9%
% from 52W High	-78.0%	-77.2%
% from 52W Low	16.3%	11.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-103.4%	-55.0%
Earnings Yield (TTM)	-118.1%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-23,871.0
EV/GP/RG	N/A	N/A
Ticker research	View ANVS research	View IBIO research